Addressing production gaps for vaccines in African countries.
作者信息
Ekström Anna Mia, Tomson Göran, Wanyenze Rhoda K, Bhutta Zulfiqar A, Kyobutungi Catherine, Binagwaho Agnes, Ottersen Ole Petter
机构信息
Department of Global Public Health, Karolinska Institutet, 171 77 Stockholm, Sweden.
Swedish Institute for Global Health Transformation, SIGHT, Royal Swedish Academy of Sciences, Stockholm, Sweden.
出版信息
Bull World Health Organ. 2021 Dec 1;99(12):910-912. doi: 10.2471/BLT.21.287381. Epub 2021 Nov 17.
Abstract
摘要
相似文献
1
Addressing production gaps for vaccines in African countries.
Bull World Health Organ. 2021 Dec 1;99(12):910-912. doi: 10.2471/BLT.21.287381. Epub 2021 Nov 17.
2
Improving access to affordable vaccines for middle-income countries in the african region.
Vaccine. 2019 May 9;37(21):2838-2842. doi: 10.1016/j.vaccine.2019.03.077. Epub 2019 Apr 9.
3
A decade of rotavirus vaccination in Africa - Saving lives and changing the face of diarrhoeal diseases: Report of the 12 African Rotavirus Symposium.
Vaccine. 2021 Apr 22;39(17):2319-2324. doi: 10.1016/j.vaccine.2021.03.014. Epub 2021 Mar 26.
4
Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference.
Pan Afr Med J. 2016 Feb 29;23:53. doi: 10.11604/pamj.2016.23.53.9097. eCollection 2016.
5
Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
S Afr Med J. 2020 May 29;110(6):525-531. doi: 10.7196/SAMJ.2020.v110i6.14332.
6
New vaccine introductions in Africa before and during the decade of vaccines - Are we making progress?
Vaccine. 2019 May 31;37(25):3290-3295. doi: 10.1016/j.vaccine.2019.05.002. Epub 2019 May 7.
7
Targeted FMD Vaccines for Eastern Africa: The AgResults Foot and Mouth Disease Vaccine Challenge Project.
Viruses. 2021 Sep 14;13(9):1830. doi: 10.3390/v13091830.
8
Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Vaccine. 2017 Oct 20;35(44):6024-6029. doi: 10.1016/j.vaccine.2017.04.005. Epub 2017 Apr 21.
9
New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
Vaccine. 2012 Sep 7;30 Suppl 3:C3-8. doi: 10.1016/j.vaccine.2012.05.086.
10
Regulatory framework and requirements for managing risks associated with veterinary biological products in Africa: present systems and future needs.
Rev Sci Tech. 1995 Dec;14(4):1171-84. doi: 10.20506/rst.14.4.903.
引用本文的文献
1
Plant-based edible vaccines: Can cholera be the case study in Africa?
J Genet Eng Biotechnol. 2025 Sep;23(3):100527. doi: 10.1016/j.jgeb.2025.100527. Epub 2025 Jun 23.
2
Cholera in Sub-Saharan Africa: Unveiling neglected drivers and pathways to elimination.
PLoS Negl Trop Dis. 2025 Apr 23;19(4):e0013029. doi: 10.1371/journal.pntd.0013029. eCollection 2025 Apr.
3
Ethical Frameworks and Global Health: A Narrative Review of the "Leave No One Behind" Principle.
Inquiry. 2024 Jan-Dec;61:469580241288346. doi: 10.1177/00469580241288346.
4
Life Science 2.0: reframing the life science sector for 'the benefit on mankind'.
Glob Health Action. 2024 Dec 31;17(1):2330758. doi: 10.1080/16549716.2024.2330758. Epub 2024 Apr 5.
5
Monkeypox vaccination in the global south: Fighting a war without a weapon.
Clin Epidemiol Glob Health. 2023 Jul-Aug;22:101313. doi: 10.1016/j.cegh.2023.101313. Epub 2023 May 19.
6
Decolonising vaccine production: Unpacking Ghanaians' support for made-in-Africa vaccines.
Vaccine X. 2023 Mar 17;14:100283. doi: 10.1016/j.jvacx.2023.100283. eCollection 2023 Aug.
7
Access to COVID-19 Vaccines: A New Global Approach.
Vaccines (Basel). 2022 Oct 25;10(11):1795. doi: 10.3390/vaccines10111795.
8
Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers.
Ann Med Surg (Lond). 2022 Aug 18;81:104366. doi: 10.1016/j.amsu.2022.104366. eCollection 2022 Sep.
9
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives.
EMBO Mol Med. 2022 Aug 8;14(8):e16287. doi: 10.15252/emmm.202216287. Epub 2022 Jun 27.
本文引用的文献
1
Vaccine manufacturing capacity in low- and middle-income countries.
Bull World Health Organ. 2021 Jul 1;99(7):479-479A. doi: 10.2471/BLT.20.273375.
Zotero 插件